EcoDrugPlus

Disintegrin And Metalloproteinase Domain-Containing Protein 17-Like

Ensembl ID : ENSOMEG00000007900
Gene Symbol: LOC112149788
3 Cross references
208 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSOMEG00000011170
Gene Symbol: DRD1
2 Cross references
189 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSOMEG00000005994
Gene Symbol: DRD1B
1 Cross references
199 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSOMEG00000015114
Gene Symbol: DRD2
3 Cross references
208 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSOMEG00000006687
Gene Symbol: DRD3
3 Cross references
203 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSOMEG00000006467
Gene Symbol: DRD4
3 Cross references
165 Possible Orthologues:

Dopamine Receptor D4b

Ensembl ID : ENSOMEG00000011534
Gene Symbol: DRD4B
1 Cross references
181 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSOMEG00000002891
Gene Symbol: DRD5
2 Cross references
147 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSOMEG00000012494
Gene Symbol: ENPP2
3 Cross references
226 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSOMEG00000019273
Gene Symbol: EGLN1
3 Cross references
220 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSOMEG00000014031
Gene Symbol: EGLN2
3 Cross references
191 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSOMEG00000005866
Gene Symbol: EGLN3
3 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).